Loading...

ACON ACLARION INC Investments/Divestments 8-K Filing

CLRN

CN

ACLARION INC

(ACON)

2024 8-K

Show Summary

Summary

Management Changes

Investor Updates

Financing Update

Stockholder Meeting

Special Meeting

Agreement Termination

Annual Meeting Results

Equity Line Amendment

Nasdaq Compliance Issues

Funding Agreement

Stock Split Approval

Financing Agreement

Subscription Agreement

Product Coverage

Quorum Reduction

Capital Funding

Public Offering

Financial Statements and Ex...

Exchange Agreements

Exchange Agreement

Reverse Stock Split

Annual Meeting of Stockholders

Stock Purchase Agreement

Tranche 2 Closing of Unsecu...

Delisting Notice and Change...

Material Definitive Agreement

Delisting Notice

Securities Purchase Agreement

Financial Restatement

Delisting Notice

Stock Split and Preferred S...

Accountant Resignation

Entry into Material Definit...

External Links:

Aclarion, Inc. announced that its Nociscan product has received initial payer coverage from AXA for the greater London area in the UK.

AI Assistant

ACLARION INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.